BamSEC and AlphaSense Join Forces
Learn More

NovaBay Pharmaceuticals Inc.

NYSE American: NBY    
Share price (1/3/25): $0.62    
Market cap (1/3/25): $3.017 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 9 pages Secured Promissory Note
12/34/56
EX-10.1
from DEFA14A 9 pages Secured Promissory Note
12/34/56
EX-10.1
from 8-K 18 pages Novabay Pharmaceuticals, Inc. and Equiniti Trust Company, LLC as Warrant Agent Warrant Agency Agreement Dated as of July 29, 2024 Warrant Agency Agreement
12/34/56
EX-10.1
from 8-K 9 pages June 14, 2024 [●] Re: Warrant Exercise Agreement to Whom It May Concern
12/34/56
EX-10.8
from 10-K 2 pages Non-Employee Director Compensation Plan January 1, 2024
12/34/56
EX-10.4
from 8-K 3 pages Consent and Release
12/34/56
EX-10.3
from 8-K 14 pages First Amendment to Security Agreement
12/34/56
EX-10.1
from 8-K 9 pages License and Distribution Agreement
12/34/56
EX-10.1
from 8-K 12 pages December 21, 2023 [ ] Re: Series B Warrant Exercise Agreement to Whom It May Concern
12/34/56
EX-10.3
from 8-K 2 pages Second Amendment to Executive Employment Agreement
12/34/56
EX-10.5
from 8-K 28 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 2 pages To: Novabay Pharmaceuticals, Inc. (The “Company”) and the Purchasers (As Defined in the Securities Purchase Agreement, Dated April 27, 2023, by and Between the Company and the Purchasers Signatory Thereto (The “Purchase Agreement”)) to Whom It May Concern
12/34/56
EX-10.3
from 8-K 16 pages Subsidiary Guarantee
12/34/56
EX-10.2
from 8-K 31 pages Security Agreement
12/34/56
EX-10.1
from 8-K 46 pages Securities Purchase Agreement
12/34/56
EX-10.33
from 10-K 7 pages Consulting Agreement
12/34/56
EX-10.15
from 10-K 2 pages Non-Employee Director Compensation Plan January 1, 2023
12/34/56
EX-10.7
from 8-K 4 pages Leak-Out Agreement
12/34/56
EX-10.6
from 8-K 3 pages Form of Additional Voting Commitment
12/34/56
EX-10.5
from 8-K 2 pages Form of Participant Voting Commitment
12/34/56